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Abstract:

Cancer is the second leading cause of death in the United States, and with the
rates of breast cancer increasing steadily over time there is a need to develop new anti
cancer treatments. This research seeks to investigate how triptolide, an extract from
the Chinese herb Tripterygium wilfordii Hook F, induces apoptosis in human breast
cancer cells. Studies have shown that triptolide can act as an anti-proliferative, anti
inflammatory, and anti-cancer agent in many different clinical applications. It has been
used for over two centuries in Chinese medicine and is now used to treat certain
autoimmune diseases, such as rheumatoid arthritis. With breast cancer plaguing the
United States as the second leading cause of cancer related deaths amongst women, as
well as the adverse effects of current treatment methods, there is a need for the
development of safer and alternative therapies. Triptolide is known to induce apoptosis
in many cancer cells lines, but the exact mechanisms that regulate this are largely
unknown. It has been suggested that triptolide activates the p53 pathway to trigger
apoptosis in these cells. However, our results demonstrate that other cellular
mechanics are at work in conjunction with p53, such as the differential regulation of
pro- and anti-apoptotic proteins; lysosomal degradation; and a change in mitochondrial
membrane permeability suggesting the release of cytochrome c.
Our studies examined the ability of triptolide to regulate the protein expression
levels of caspase-3, caspase-7, and caspase-9, poly (ADP-riobse) polymerase (PARP),
and Bcl-2 via colorimetric Western blot analysis. Apoptosis was monitored using the
MTT cell viability assay and morphological observations. LysoTracker™ and
MitoTracker™ were used to stain lysosmes and mitochondria, respectively. An acid
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phosphatase, a marker enzyme for lysosomes, assay was conducted in order to measure
the activity of lysosomal enzymes. Our results demonstrated that the amount of
apoptosis, which was significantly increased by triptolide, was both time- and dosedependent, suggesting that there may be an optimal triptolide concentration for
maximal anticancer efficacy. Triptolide also differentially regulated the expression of
pro- and anti-apoptotic proteins. Furthermore, the apoptotic death of cells was shown
to be a lysosomal-mediated cell death. Future investigations will try to decipher the
molecular mechanisms by which triptolide regulates apoptosis in vivo using an MCF-7
xenograft model in nude mice.
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Introduction:

Breast cancer is the second most common cancer among women in the United
States and the National Cancer Institute now estimates that one in seven individuals
living in the United States will develop breast cancer in their lifetime. With rates of
breast cancer increasing, it is estimated there will be 1.5 million new cases worldwide
in 2010 [1]. Current treatments such as chemotherapy and radiation are known to have
harmful side effects on normal somatic cells therefore; it is imperative to develop safer
and non-invasive treatments. The use of natural products in the fight against cancer is
one possible way of slowing tumor growth and may allow us to design more effective
therapies.
Cancer is a genetic disease, in part, where there is a loss of control over the cell
cycle resulting in uncontrolled and unchecked cell proliferation. When the checkpoints
of the cell cycle become mutated, cells are capable of reproducing at alarming rates, the
danger lies when a cell that has accrued mutations is allowed to proliferate unchecked.
Now these cells can continue to divide and also pass on these mutations creating clones
that have the same mutations [2]. These mutations allow the cancer cells to evolve and
can be lethal to the patient. Cysts, or benign tumors are non-invasive and noncancerous, they are simply a collection of rapidly diving cells [2]. On the other hand,
malignant tumors are cancerous and can spread throughout the circulatory or
lymphatic, colonize at distant sites, and eventually kill the patient [3].
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Cancer is the result of an accumulation of mutations over time that leads to a
cell becoming cancerous. While there is no definitive cause of cancer, several factors
play key roles in triggering mutations. On a molecular level, there are several factors
that can contribute to mutating the cell cycle. Proto-oncogenes, which function
normally to regulate the cell cycle, when mutated, give rise to oncogenes, which are
responsible for promoting excessive cell division [4]. The other category of genes that
play a role are tumor-suppressor genes, such as p53, which normally block excessive
cell growth and induces apoptosis. When mutated tumor suppressor genes function as
tumor promoters and allow for the cells to divide unchecked [5].
Environmental factors such as smoking, exposure to UV light, and diets high in
fat can also increase the risk of cancer [6, 7] as well as many genetic factors. The
passing on of genetic mutations in genes BRCA1 and BRCA2 account for as much as
10% of all reported cases of human breast cancer [6, 8, 9]. It appears that women who
come from families with a history of breast cancer seem to have the highest incidence
of cancer caused by these genetic mutations [9], suggesting there is a genetic link
between the incidence of breast cancer and familial history. While individuals who test
positive for the BRCA1/2 gene are more likely to develop breast cancer it is not a
guarantee [9].
Tumors are in an ever-changing environment [10, 11,12] thus the tumor itself
is constantly adapting to survive. Since the cells are always changing, treatment
options are also limited to the types of cancer they can fight. When tumors change,
they can adapt by becoming chemoresistant, developing resistance to radiation, or
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mutating tumor-suppressor genes (i.e. p53) to give themselves a survival advantage
over normal cells. Because of cancers cells resistance to many treatments and the
harmful side effects of current treatments, alternative methods need to be explored.

Tritpolide (Figure 1), a biologically active extract from the Chinese herb
Tripterygium wilfordii Hook F is a diterpenoid triepoxide. For centuries, the herb has
been used in Chinese medicine to treat chronic pain due to inflammation [13, 14]. The
properties of triptolide’s unique structure are what allow it to act as an anti
inflammatory, anti-proliferative, and anti-cancer agent. Looking at the chemical
composition of triptolide, it is a derivative of isoprene, which is part of the terpene
family. The structure of triptolide, being a diterpenoid means its base is made up of
four isoprene molecules [15] as well as other constituents. What is most interesting
about the isoprene units is that through biosynthesis in some plant leaves, certain pre
cursors to vitamins A (retinol) and E (tocopherol) are derived [15,16]. Being that
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these are both strong antioxidants this is one way triptolide can act as an anti-cancer
agent. Furthermore, triptolide is known to reduce proliferation by sequestering
production of T and B-cells, which are known to increase inflammation [16]. While
most cancer drugs work to activate tumor necrosis factor-alpha (TNF-a) which is
known to induce apoptosis in cancer cells, they can also be responsible for activating
nuclear factor-kappa-beta (NF-k(3). NF-k|3 is responsible for tumor promotion [17], the
result is having these two processes cancel each other out. Triptolide is solely
responsible for activating TNF-a while preventing the activation of NF-k|3 [17, 18].
Triptolide is known to induce apoptosis, and impede tumor growth in a variety
of cancer cell lines [19, 20, 21]. Apoptosis, or programmed cell death, is vital during
embryonic development and throughout the life of all eukaryotic organisms because it
removes damaged cells before they become cancerous [22]. Apoptosis, can be
compared as an opposite of mitosis, is a very structured and regimented process that
occurs naturally in somatic cells and is carried out by various enzymes that degrade
cytoskeletal components via biochemical reactions [23].
Programmed cell death is a very clean and efficient way of destroying damaged
cells. This differs greatly from another form of cell death, necrosis. Necrosis is
usually the result of cell injury, which causes rupture of the plasma membrane, thus
allowing the contents of the cell to leak out and affect neighboring cells, this leaking
cellular debris can actually cause more damage to the organism [24]. In the case of
cancer, cells that die via necrosis, or cells that lyse can cause the cancer to spread to
neighboring cells. Therefore, the most efficient way of killing cancer cells is through
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apoptosis. It is the goal of chemotherapeutic, radiation, and hormonal treatments [25,
26] often to induce apoptosis in cancer cells, however cancer cells often acquire
resistance to these treatment modalities.
While many pathways can trigger apoptosis, one of the two most common is
when cytochrome c is released from the mitochondria into the cytosol. The role of
cytochrome c is to form a structure called the apoptosome [27] that promotes apoptosis
through a cascade of reactions. The first step in the mitochondrial pathway is when
cytochrome c itself binds to a protein known as apoptosis activating factor 1 (APAF-1)
and to procaspase-9, forming the aforementioned apoptosome. Once the structure has
formed, caspase-9 (known as an initiator caspase) becomes activated which causes
cleavage of procaspase 7 to cleaved caspase 7 (executioner caspase) which begins to
degrade cell components [27, 28]. The role of the initiator caspases is to carry a
message to the executioner caspases to begin degrading cellular components. It is best
thought of as a ‘passing the baton’ where the initiator caspases pass the signal to the
executioner caspases to begin apoptosis. After the cell has activated the executioner
caspases (3,6, and 7) the cell undergoes apoptosis.
Once the cell has undergone apoptosis its cellular components must be disposed
of, this process is known as phagocytosis. During the process of apoptosis a
phospholipid that is normally found in the inner leaflet of the plasma membrane,
phosphatidylserine, migrates to the outer leaflet. This migration marks the cell and
signals nearby phagocytes that the cell is ready to be engulfed [29]. During this
process, the phagocyte engulfs the apoptotic bodies and degrades them with the help of

12

various enzymes found in lysosomes. Phagocytes can be macrophages, which are part
of the immune system, or a neighboring cell that helps to remove the degrading
apoptotic bodies [30].
Apoptosis can also be induced in a lysosomal-mediated manner [31].
Lysososmes act as “cell dumping site” where they digest damaged cellular
components, remove waste products from the cell, and are known to be a part of the
apoptotic process. This organelle contains an array of enzymes that are capable of
breaking down proteins, carbohydrates, and lipids [32]. Lysosomal-mediated apoptosis
is still largely under investigation and not fully understood, however what is known is
that the membrane of the lysosome becomes permeable. Originally, this was thought
to only be a part of necrosis [33], the release of acidic hydrolases from the lysosome
into the cytosol, now research suggests specific lysosomal proteases play an active role
in apoptosis [33, 34].
While the data on lysosomal-mediated apoptosis is still accumulating, of the
roughly 50 hydrolases present in lysosomes, cathepsins are best understood in terms of
their role in triggering apoptosis [33, 34]. What appears to occur is depending upon
how permeable the membrane of the lysosomes becomes, the cell dies via necrosis or
apoptosis. If there are large amounts of hydrolases released (as is the case in cell
trauma) necrosis will occur, however if there are lower levels present this can trigger
apoptotic signaling. Triptolide treatments create an oxidative stress [34, 35] within the
cancer cells; this can be the triggering mechanism that causes lysosmal membrane
permeabilization. In the hopes of illustrating that lysosomal pathways are also involved
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in triptolide-induced apoptosis, we examined the treated cells with LysoTracker and
acridine orange to assess the functionality of this organelle.
Triptolide has been thought to induce apoptosis exclusively via the p53
pathway [36]. However in our studies, evidence is provided to show that there are
other factors involved, starting with the activation of caspases. As previously
discussed, the mitochondrion plays a large role in apoptosis with the release of
cytochrome c into the cytosol. If there is an increase in executioner caspases this
suggests that cytochrome c was released, and also supports the notion that the
mitochondria is involved in triptolide induced apoptosis. Furthermore, the
mitochondria could induce apoptosis via a non-caspase dependent mechanism by
stimulating PARP, which can trigger an apoptosis-inducing factor. Also with the
membrane of the lysosome becoming permeable and the release of lysosomal enzymes,
apoptosis can be achieved through a lysosomal mediated manner. Seen in Figure 2 is
our proposed model for triptolide-induced apoptosis through lysosomal and
mitochondrial mediated pathways.
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Triptolide

Apoptosis
Figure 2: Proposed model of triptolide-induced apoptosis.

This research will illustrate other mechanics at work that provide evidence there are
multiple pathways contributing to the apoptosis of MCF-7 and SK-BR-3 cells when
treated with triptolide.
2. Materials and Methods:

2.1 Cell Culture:
MCF-7 and SKBR-3 were purchased from American Type Culture Collection
(ATCC, Manassas, VA). Cells were grown in «-Minimally Essential Media (aMEM;
BioWhittaker, Walkersville, MD) and supplemented with O.Olmg/mL insulin, 100
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parts/mL Streptomycin/Penicillin (ATCC), and 10% fetal bovine serum (Atlanta
Biologicals, Lawrenceville, GA). All cells were grown in T-25 flasks (Gibco, Grand
Island, NY) and incubated at 37°C in a humidified chamber at 95%02/5%C02. Cells
were subcultured by washing with a IX phosphate buffered solution (PBS; 137 mM
NaCl, 2.7 mM KC1,4.3 mM Na2HP04x7H20 , 1.4 mM KH2P04, pH adjusted to 7.4)
and using Trypisn (Invitrogen, Eugene, OR, 0.25% (w/v) Trypsin - 0.53 mM EDTA
solution).
2.2 Hemotoxylin and Eosin Staining:
Cells were allowed to grow on coverslips until confluent in six-well plates.
Upon reaching a confluent state cells were treated in the presence or absence of
triptolide (lOng/mL) and incubated at 37°C for 24 h. After treatment, coverslips were
rinsed with IX PBS and cells were fixed to the coverslips using a 4%
paraformaldehyde solution and incubating for 20 min. After cells had adhered to the
coverslips they were dipped in hematoxylin for 60 sec, and rinsed in dH20 for 2 min.
Next, cells were dipped into eosin for 30 sec and placed in solutions of 95% ethanol
and 100% ethanol for 2 min and 5 min, respectively. Slides were then fully dehydrated
in a solution of 100% ethanol for 2 min and then equilibrated in xylene by dipping for
2 min three separate times. Finally, coverslips were mounted onto slides using Crystal
Mount (Sigma, St. Louis, MO) and examined by light microscopy to examine cell
morphology.
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2.3 MTT Cell Viability Assay:
To test for apoptosis the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium
bromide (MTT) reduction assay (Sigma, St. Louis, MO) was used. Stock solutions of
MTT were prepared in aMEM at a concentration of 5 mg/mL. Cells were allowed to
grow until confluent in 6-well plates and then treated with varying concentrations of
triptolide (1 ng/mL, 5 ng/mL, 10 ng/mL, and 15 ng/mL) for 24 h. After the treatement
period, the medium was removed and replaced with 2mL of fresh medium that
contained the MTT and incubated at 37°C for 4 h. After the incubation with the MTT,
the medium was removed and acidic isopropanol was added. The acidic isopropanol
(0.1 N HC1 in 100% isopropanol) was needed in order to stop the reaction and dissolve
the tetrazolium crystal that formed. Finally, the isopropanaol was removed and
absorbance (which relates to cell viability) was measured at 570 nm. All readings were
done in triplicates.
2.4 LysoTracker ™:
Lysosomes play a crucial role in apoptosis by degrading cellular components.
Using the LysoTracker™ (Invitrogen) we can visualize lysosomes in cells. Stock
solutions of LysoTracker ™were diluted in aMEM to 5 mg/mL. Because the probe is
known to stain other cellular structures at a higher concentration, we choose to go with
50 nM as our concentration for treatment. Cells were grown in 6-well plates until
confluent and then treated for 24 h with varying concentrations of triptolide (1 ng/mL,
5 ng/mL, 10 ng/mL, and 15 ng/mL). After the incubation period, the cell culture
medium was removed and lmL of the LysoTracker™ solution and lmL of fresh
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medium was added to the wells and allowed to incubate for 45 min. After the staining
period, the probe solution was removed and replaced with regular growth medium.
Cells were immediately analyzed using fluorescence microscopy (EVOS FL,
Advanced Microscopy Group, Bothell, WA).
2.5 MitoTracker ™:
Mitochondria play a role in apoptosis by starting a cascade of caspase activity.
To look for a change in mitochondrial permilibization as well as to localize
mitochondrion, the MitoTracker™kit (Invitrogen) was used. Stock solutions (1 mM)
of MitoTracker™ were prepared by adding lmL of dH20 to the vial of MitoTracker™
dye supplied. Solutions for the assay were then diluted to 2 jxg/mL in aMEM. MCF-7
cells grown in 6-well plates until confluent and were then treated with triptolide for 24
h at varying concentrations (1 ng/mL, 5 ng/mL, 10 ng/mL, and 15 ng/mL).
Afterwards, the medium was removed and lmL of MitoTracker™-containing medium
was added in conjunction with lmL of normal medium (to give a final concentration of
1 ¡ig/mL of MitoTracker™). Cells were then incubated for 45 min at 37°C; fresh pre
warmed media was added; and images were captured via fluorescence microscopy
using the EVOS FL.
2.6 Hoescht Staining:
Cells were treated in the presence or absence of lOng/mL of triptolide for 24 h
at 37°C and then with 1 mg/mL of Hoechst for 15 min at 37°C in the dark. Images
were captured using the EVOS FL fluorescence microscope.
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2.7 Acridine Orange:
Cells were grown on coverslips and incubated for 24 h in the presence or
absence of triptolide. Afterwards a 5 mg/mL stock solution of acridine orange was
prepared by dissolving 5.0 mg of acridine orange in 5mL aMEM. The medium was
removed from the wells and 1 mL of acridine orange-containing medium as well as 1
mL of fresh pre-warmed medium was added and allowed to incubate for 15 minutes.
Cells were rinsed with IX PBS and coverslips were mounted using Crystal Mount.
Cells were examined using fluorescence microscopy.
2.8 Protein Isolation
Cells were treated at varying concentrations of triptolide (1 ng/mL, 5 ng/mL, 10
ng/mL, and 15 ng/mL) for 24 h in 6-well plates. After incubation, the medium was
removed and cells were rinsed once with IX PBS. Two hundred pi of SoluLyse-M
(Genlantis San Diego, CA) were added to each well and incubation occured at room
temperature for 10 min. Cell lysates were then collected and transferred to Eppendorf
tubes, which were centrifuged for 5 min at 14,000 g. Supernatants were transferred into
clean Eppendorf tubes for futher analysis.
2.9 BCA Protein Concentration Determination
Once proteins were extracted from the cells, the BCA Protein Assay Kit (Pierce
Rockford, IL) was used to determine protein concentration. A preparation of diluted
bovine serum albumin (BSA) was made in order to generate a standard curve in which
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the unknown samples could be compared. As provided by the kit each ampule
contained 2.0mg/mL of the albumin standard, enough to perform three replications of
each diluted sample. The range prepared, as suggested by the manufacturer, was from
2,000pg/mL to Opg/mL (blank).
After preparation of the standards, the BCA working solution was prepared
using the following formula: (# of standards + # of unknowns) x (# of replicates) x
(volume of working reagent per sample, 2.0mL) = total volume of working reagent
needed (Pierce). The working reagent was prepared by adding 50 parts of BCA
reagent A to 1 part of BCA reagent B (50mL Reagent A with lmL Reagent B).
To begin the protein analysis, lOpl of each standard and unknown were added
to labeled test tubes. Next, 200pl of the working reagent was added and the tubes were
vortexed for 5 sec. Tubes were then incubated for 30 min at 37°C to allow the reaction
to proceed. Samples were then analyzed at 562nm using the Nano-Drop 2000
Spectrophotometer (Thermo Scientific, Waltham, MA). A standard curve was
generated and the protein concentrations of the unknown samples were determined.
2.10 SDS-Page
SDS-Page was performed using 10% EZ-Run protein gel solution (Fisher
Scientific, Pittsburg, PA) and the E-Run running buffer. First 130pl of freshly
prepared 10% ammonium persulfate (500mg in 5mL dH20) and 12pl of
tetramethylethylenediamine (TEMED) were added to lOmL of the EZ-Run protein gel
solution. The solution was added to the gel chamber with a comb present and allowed
to polymerize for 20 min. While waiting for polymerization to occur, samples were
20

prepared by the addition of Laemmli’s SDS-sample buffer (Tris-HCl [250 mM, pH,
6.8], SDS [8%], glycerol [40%], |3ME [8%], and bromophenol [0.02%]), and boiling
for 5 min. A stock solution of IX EZ-Run running buffer was prepared from the 20X
EZ-Run running buffer. Upon polymerization, the comb was removed and the wells
were rinsed with the SDS-PAGE buffer and samples were loaded to each well.
Standard IX loading dye was added to each empty well to prevent the proteins from
shifting during electrophoresis. Gels were run at 150 V for 60-90 min, or until the
samples reached the bottom of the gels.
2.11 Coomassie Staining
After SDS-PAGE, gels were incubated in a Coomassie blue solution (2g in
lOOmL) for 1 h and then destained overnight in the destaining solution (100 mL acetic
acid, 450 mL methanol, 450 mL dH20). Both staining and destaining were done with
gentle shaking to allow for the gel to be completely exposed to both solutions.
2.12 Colorimetric Western Blot Analysis:
Following the SDS-PAGE, proteins were transferred to PVDF membranes.
Transfer buffer (25mM Tris, 192mM glycine, 20% Methanol, 775mL dH20 , and pH
adjusted to pH of 8.3) was made in order to transfer the proteins. To make the trans
membrane blot sandwich 6 pieces of Whatman paper, the PVDF membrane (pre
treated for a few sec in 100% methanol), and the sponges were all soaked in the
transfer buffer. Then the trans-blot sandwich was built using the cassette with a
sponge, three pieces of Whatman paper, the membrane, the gel, three more pieces of
Whatman paper, and the last sponge. Together this was placed into the transfer
21

chamber and filled with the transfer buffer. The apparatus was run for 2 h at 130V.
After the transfer was complete, the membranes were removed from the apparatus and
rinsed in IX PBS for 5 min.
To visualize the proteins, membranes were first blocked for 1 h at room
temperature in the blocking buffer (IX TBS) and then rinsed for 5 min in a IX PBS
solution. Primary antibodies were purchased from Cell Signaling (Danvers, MA) and
were raised in rabbits. Primary antibody incubation occurred at a dilution of 1:500
(Dilution Buffer IX PBS-T) for 24 h at 4°C. Following the incubation period
membranes were washed in wash buffer (IX PBS) for 1 h at room temperature.
Subsequently, secondary antibodies (Goat-anti Rabbit) were incubated with
membranes for 1 h a room temperature, membranes were then washed for 30 min.
Finally, to visualize bands then membranes were incubated in a solution of Blue Liquid
Substrate (Sigma- BCIP/NBT) for 30 min. Once the bands began to develop the
solution was decanted and dFl20 was added to terminate the reaction and minimize
high background. Bands were then compared to the molecular weight standards to
confirm the presence of the protein-of-interest.
2.13 Acid Phosphatase:
Cells were treated in the presence or absence of triptolide for 24 h at 37°C and
were then transferred into a 0.9% NaCl solution and centrifuged for 5 minutes at
10,000 g. Cells were then placed in the reaction mixture (0.5 mL p-nitophenol
phosphate, 0.5 mL 90mM citrate buffer [pH=4.8], and 0.1 mL of centrifuged cells) and
allowed to incubate for 30 min at room temperature. The reaction was terminated with
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the addition of 0.5mL 0.1 N NaOH. Samples were then analyzed
spectrophotometrically at 410 nm.
2.14 Statistical Analyses:
Student ¿-tests were performed to check for statistical significance. MTT
absorbance values for triptolide treated cells were considered statistically significant
with a p-value <0.05.
3. Results

3.1 Hemotoxylin and Eosin Staining
Cancer cells exhibit morphology quite different from that of normal somatic
cells, such as hypertrophic nuclei, irregularity in cell membrane, and loss of anchoragedependence [37]. We examined the affect of triptolide treatment on the morphology of
MCF-7 cells by using hematoxylin and eosin staining. Control cells displayed normal
breast cancer cell morphology - cells formed outgrowths and domes (Figure 3, left
panel). Cell shrinkage, blebbing [19] of the plasma membrane, and fragmented cells
were detected in response to triptolide treatment (Figure 3, right panel). These data
suggest that triptolide induces morphological changes in the cells that are consistent
with apoptotic cell death.
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Control

Experimental

Figure 3: Hematoxylin and Eosin Staining. Control cells are nearly confluent
and show normal morphology (left panel). However in cells treated with lOng/mL
triptolide cells have shrunk and become fragmented (right panel). Shown are
representative images from three independent experiments. Magnification at
400x.

3.2 MTT Cell Viability Assay
The MTT cell viability assay is a quantitative way of examining cell
proliferation by spectrophotometric means. Mitochondrial function in viable cells
reduces the tetrazolium salts through metabolic pathways into insoluble formazan
crystals [38]. Therefore, the more cells that are undergoing apoptosis the fewer purple
formazan crystals will be present, thus suggesting apoptosis is occurring in these cells.
For our purposes both MCF-7 and SK-BR-3 cells were treated in the presence or
absence of triptolide at varying concentrations and for prolonged time periods to
determine if there was a dose-dependent and/or time-dependent relationship in
conjunction with triptolide treatments.
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As seen in Figure 4A, MCF-7 cells exhibited an increase in cell death with
increasing concentrations of triptolide. All OD readings were done in triplicates and an
average was taken. Student ¿-tests were performed on the absorbances to check for
statistical significance and all p-values were <0.05. The results represent percentage
of cell death in comparison to control cells. SK-BR-3 cells also demonstrated the same
behavior with an increase in triptolide concentration causing an increase in cell death
(Figure 4B).

Dose-Dependent MCF-7 Cell
Death
80

Dose-Dependent SK-BR-3 Cell
Death
70
60

1
Concentration of Triptolide (ng/mL)

5

10

15

Concentration of Triptolide (ng/mL)

Figure 4: Dose-Dependent MTT results for MCF-7 and SK-BR-3 cells. Shown
here both cell lines show an increase in cell death when treated with a higher
concentration of triptolide. Student ¿-tests were performed and yielded p-values
<0.05. Data shown below (* indicates p< .05, ** indicates p< .001). Studies were
conducted in triplicates and the values are from three independent experiments.
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To examine whether triptolide had an effect over an extended period of time, a
time-series study was conducted as well. Cells were treated with lOng/mL (LD50) for
24 h, 48 h, and 72 h and again the cell viability was measured. As seen in Figure 5A
and 5B in both MCF-7 and SK-BR-3 there was an increase in cell death the longer the
cells were exposed to triptolide.

Figure 5: Time-dependent MTT results for MCF-7 and SK-BR-3 cells. Cell lines
also showed that with longer incubation periods of triptolide cell viability
decreased. However, it is worth noting that between 24 and 48 h the change in cell
death was only 3.5%. Again student t-tests were performed and all p-values were
<.05. Data shown on next page (* indicates p< .05, ** indicates p< .001). Studies
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were conducted in triplicates and the values are from three independent
experiments.
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3 3 Immunofluorescence Staining
The beauty of immunofluorescence assays is that they show localization of the
target (whether it be a protein, an organelle, or DNA) within the cell. In these studies
all three are tested to exhibit different ways that triptolide can cause cancer cells to
undergo apoptosis. Through the use of the MitoTracker™ and LysoTracker™ the
organelles are directly stained to show their functionality before and after treatment.
Hoescht staining is done to check for chromatin condensation, a definitive
characteristic of apoptotic cells. Acridine orange, which collects in acidic
environments, is also done to test for lysosmal-mediated apoptosis. Together with the
LysoTracker™ staining we hoped to show that there was a link between triptolide
treatments and lysosomal mediated apoptosis in cancer cells.
As previously mentioned there are two organelles that participate in pathways
that are crucial steps of apoptosis: the mitochondria, and lysosomes. Mitochondria,
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with the release of cytochrome c, play a vital role in triggering a cascade of caspases
resulting in the cleavage of various cellular substrates. Using the MitoTracker and
LysoTracker immunofluorescence assays, we demonstrated how these organelles are
affected by triptolide. Apoptosis is an endergonic reaction requiring a large amount of
energy to breakdown the cellular components [39]. By using MitoTracker™ we can
look for an increase in mitochondrial activity. In Figure 6, we compared the control
cells with experimental cells (those treated with lOng/mL of triptolide) for
mitochondrial activity.
Control

Experimental

Figure 6: R esults of MCF-7 M itoTracker w h en treated with triptolide. We
detect an increse in mitochondrial activity in experiemental cells, possibly
suggesting a membrane permiability change. Shown are representative images
from three independent experiments.

Experimental cells were more active and had a change in membrane
permeability suggesting that cytochrome c may have been released into the cytosol.
This was detected because the dye was able to collect within the mitochondria. If this
is the case, we can also expect to detect the activation of caspases through Western.
These results lead us to believe that triptolide is successful at causing various
pathways, other than p53, to become active and aid in the process of apoptosis. Now in
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figure 7, lysosomal function was examined using the LysoTracker™ assay. Here again
we notice that in the experimental cells they are almost completely fluorescing
suggesting that lysosome are beginning to degrade the cellular components [40]. This
is a hallmark of apoptosis, with cellular machinery needing to be broken down.
Control

Experimental

Figure 7: R esults o f MCF-7 LysoTracker in the p resen ce and ab sen ce o f
T riptolide. As seen in the experim en tal cells (right panel) lysosom al activity
w as m uch higher than in the control cells. This could be due to triptolide
activating lysosom al m ediated apoptosis. Shown are representative images
from three independent experiments.

For further support that apoptosis is mediated using lysosomes when treated
with triptolide we used the acridine orange assay which is a fluorescent dye that
accumulates in acidic environments. Because lysosomal-mediated apoptosis is still not
widely accepted, we used multiple assays to assert our claim. As seen below in Figure
8, cells were stained with acridine orange in the presence and absence of triptolide.
What we illustrate is that within the control cells, the signal detected is mostly red.
This indicates that the hydrolases that acrdine orange recognizes are primarly still
within the intact lysosome. However in the right panel, showing experimental cells,
the green color represents a change in lysosomal membrane permeability suggesting

29

that the contents of lysosomes have now spilled out into the cytosol of the cells. This
release of hydrolases can trigger apoptosis to occur in triptolide treated cells.

Figure 8: Control cells (top panel) show primarly red staining, which signifies that
most of the hydrolases are located within the lysosomes. Seen in the experimental
cells (lower panel) the green color indicates a change in lysosomal membrane
permeability resulting in the hydrolases collecting in the cytosol.

DNA fragmentation and eventually degradation is the final step in the process
of apoptosis. The destruction of the nuclear envelope thus exposing the DNA to
various proteases and caspases allows for the genetic information of the cell to be
disposed of [41]. This is of particular importance in cancer because if the genome of
the cell is mutated, the DNA is the most crucial part to destroy so no other cells can
take on that cancerous mutation. Through the use of the Hoescht stain we display the
effects of triptolide on cancer cells in detecting chromatin condensation. In Figure 9
we can detect chromatin condensation, a hallmark of apoptosis within the
experimentally treated cells. This was not detected in the control cells.
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Control

Experimental

Figure 9: Seen here MCF-7 cells treated with triptolide exhibit chromatin
condensation detected with Hoechst stain (right panel). Control cells (left panel)
which do not exhibit this condensation. Shown are representative images from
three independent experiments.

3.4 Western Blotting
Apoptosis is regulated by the cyclic patterns of various proteins, when certain
proteins are expressed the next phase of apoptosis can occur. Continuing with this
idea, it is the proteins themselves that are responsible for the cellular breakdown, with
different proteolytic reactions that take place. It was our intent to see how triptolide
regulated various proteins, including those that are pro- and anti-apoptotic, proteins
that are the result of tumor suppressor genes, as well as different caspases, which are
part of a cascade resulting in cleavage of many cellular components leading to the
formation of apoptotic bodies.
Western blot analyses were done using colorimetric reagents on samples that
came from triptolide treated cells, as well as control cells. In Figure 10, we are looking
at the way triptolide affects pro-apoptotic and anti-apoptotic proteins. Because cancer
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cells are looking to proliferate and colonize at distant sites, cell death avoided by
causing an up-regulation of anti-apoptotic proteins. One such protein is Bcl-2, which is
responsible for maintaining cell homeostasis and sequestering apoptosis from occurring
[36]. Conversely, p53 is an example of a pro-apoptotic protein which is known to play
a large role in causing apoptosis [11,24,42].
The p53 protein is known to play many roles as an anticancer agent by inducing
DNA repair enzymes, stopping angiogenesis, causing arrest in the cell cycle at the G,/S
gap to allow for DNA repair to occur, or if the DNA is too badly damaged initiating
apoptosis [42]. Therefore this protein is essential to maintaining genome stability and
without it, cells are able to proliferate unchecked. Normal cytosolic concentrations of
p53 are quite low [42,43], however in apoptotic cells this concentration is increased.
We tested for the up-regulation of p53 and the down-regulation of Bcl-2 in cells that
were treated with triptolide through Western blotting using antibodies against each of
the proteins of interest. Our rationale was that if apoptosis is occurring, we should find
higher levels of p53 and steadily decreasing levels of Bcl-2. According to Figure 10
our assumptions were supported, in the experimental cells we find that both p53 and
Bcl-2 are differentially regulated where p53 was up-regulated to promote apoptosis,
and Bcl-2 concentrations fell.
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Figure 10: Western Blot analysis for p53 and Bcl-2. Triptolide treated cells
expressed a decrease in Bcl-2 and an increase in p53 protein expression. Lane 1MW standard, Lane 2- Control, Lane 3 -1 ng/mL, Lane 4- 5 ng/mL, Lane 5-10
ng/mL, Lane 6-15 ng/mL.

Caspases themselves are part of a cascade system which work to carry
messages (initiator caspases) and induce apoptosis (executioner caspases). As
previously mentioned, caspases play vital roles in apoptosis and because this system
depends on the formation of an apoptosome, high cytosolic levels of caspases could
signify a mitochondrial mediated pathway at work. In our study, we treated cells with
varying concentrations of triptolide and then measured caspase concentration through
Western blot analysis; Figure 11 shows the results of these tests. We first looked for
the presence of cleaved caspase-9, an initiator caspase. Cleaved caspases are ones that
are active, when they received a signal to start functioning part of the caspase that is
not necessary is cleaved off.
As seen in the figure, this initiator caspase showed an increase in band size
upon treatment with higher concentrations of triptolide. Also, seen in Figure 11 are the
results for cleaved caspase-7, an executioner caspase. Similar to the results found in
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cleaved caspase-9 are shown below, with the overall concentration increasing with
more triptolide. Lastly, caspase-3 another initiator caspase was not detected (data not
show) this is because caspase-3 does not exist in MCF-7 cells, as suggested by Janicke
et al. (1998) [44]. Caspase-3 does not exist in these cells because of a 47 basepair
deletion on exon 5 resulting in caspase-3 not being expressed.
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Figure 11: Western blot analyses show that with increasing concentrations of
triptolide treatments there is an increase in both initiator and executioner
caspases. Lane 1- MW standard, Lane 2- Control, Lane 3 -1 ng/mL, Lane 4- 5
ng/mL, Lane 5-10 ng/mL, Lane 6-15 ng/mL.

Poly (ADP-ribose) polymerase, or PARP, is a unique protein in that it can
repair DNA damage, mediate post-translation modifications to proteins, and can
directly induce apoptosis [45]. When DNA damage is detected PARP can induce
apoptosis by producing a protein called PAR which causes the mitochondria to release
apoptosis inducing factor (AIF) [46]. This pathway is thought to be independent of the
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caspase cascade because it is first triggered by PARP detecting DNA damage. PARP
expression was tested for in the same way that the other proteins were and the results
showed results similar to those from the above figures. Figure 12 shows that PARP
expression increased in response to increasing concentrations of triptolide treatment.
This could suggest that triptolide successfully activates PARP to detect DNA damage
and induce apoptosis. Through Western blotting analyses we were able to demonstrate
how triptolide is able to differentially regulate various pro- and anti- apoptotic proteins.
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Figure 12: Expression of cleaved PARP was shown to have increased in response
to higher dosages of triptolide treatments. Lane 1- MW standard, Lane 2Control, Lane 3-1 ng/mL, Lane 4- 5 ng/mL, Lane 5- 10 ng/mL, Lane 6- 15 ng/mL.

3.5 Acid Phosphatase
To further confirm that apoptosis is mediated in a lysosomal-mediated manner
upon treatment with triptolide, an acid phosphatase assay was conducted. Acid
phosphatase, as previously mentioned, is a marker enzyme for lysosomes and its
increase is used to monitor apoptosis [47,48], It works on the presence that acid
phosphatases work to remove phosphate groups from phosphoric acids in acidic
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environments; therefore if lysosomes are more active we expect to find higher levels of
acid phosphatase [49]. This rationale holds true as seen in Figure 13, the activity of
lysosomal enzymes were much higher after a 24 h treatment with triptolide compared
with the control cells, suggesting a role for lysosomes in apoptosis.

Acid P h o sp h a ta se for MCF-7 Cells

Incubation Time

Figure 13: Acid phosphatase, which measures lysosomal activity, shows that
lysosomes are much more active in the 24 and 72 h treatments in comparison with
the control. Studies were conducted in triplicates and the values are from three
independent experiments.

4. Discussion

It was the goal of this research to investigate possible mechanisms by which
triptolide, an extract from the Chinese herb Tripterygium wilfordii Hook F, induces
apoptosis in human breast cancer cells. Current research suggests that triptolide is
responsible for activating the p53 pathway and causing cell death, however our
research offers additional alternatives. By triggering apoptosis in breast cancer cells
we are able to suggest a clean and efficient manner by which these cells can be killed
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off without harming or infecting neighboring cells. The nature of triptolide to act as an
anti-inflammatory, anti-cancer, and anti-proliferative agent makes it a great alternative
to current methods of treatment. The side effects of chemotherapy and radiation can be
debilitating to the patients health [50,51] and in some cases actually make the cancer
worse or bring on a new type of cancer [50], for these reasons new and safer alternative
treatment methods need to be investigated.
Apoptosis is a complicated process by which damaged cells are degraded in a
very clean and efficient way. Many types of death stimuli such as DNA damage, loss
of control over the cell cycle, protein interactions, as well as a host of other
implications also control this process. Because apoptosis is so complex, we believe
that when cancer cells are treated with triptolide there are multiple pathways activated
to bring about this cell suicide. It has already been widely accepted that triptolide is
responsible for activating the p53 pathway [36, 52] however we sought to investigate
how mitochondrial and lysosomal involvement could aid in the cells destruction.
First, we examined exactly what tritptolide did upon treatment and looked for
morphological changes as well as its affect on cell viability. The results were evident
after hematoxylin and eosin staining that the cell morphology changed greatly,
displaying cell shrinkage and fragmentation within the triptolide-treated cells, as would
be expected in apoptotic cells. Next, we wanted to assess overall cell viability to see
how and if triptolide worked at increasing cell death. Both MCF-7 and SK-BR-3 cells
exhibited dose- and time-dependent relationships in response to their exposure to
triptolide. Cell death (which was compared to the control) increased at higher
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concentrations of triptolide and an LD50 was established around lOng/mL. This
concentration was then used in time-series studies and we showed that cells that were
exposed to triptolide longer also experienced more cell death. These correlations did
not come as a big surprise as triptolide is known to induce apoptosis in other cancer
cell lines [53, 54].
To determine if mitochondrial function played a role, we first looked for
activity of the mitochondria using MitoTracker™. With an increase in fluorescence
signal from triptolide treated cells compared to control cells, this suggested a change
in the membrane permeability of the mitochondria occured allowing them to become
more permeable. If there was a change in the permeability of the membrane, this could
allow for the release of cytochrome c, one of the first steps in triggering the caspase
cascade. Because caspases are known to play a vital role in apoptosis it would be
expected that they are involved in triptolide-mediated apoptosis. To test for this,
Western blot analyses were conducted to examine if the expression levels of different
initiator and executioner caspases. Our results indicate there is an increase in
expression of caspases-7 and -9 both of which are part of the caspase cascade
responsible for triggering apoptosis [43,44]. Caspase 3, another caspase that is vital
for the caspase cascade was not detected, however this is due to the fact that MCF-7
cells do not code for caspase-3 [44]. MCF-7 cells have a 47-base pair deletion on exon
three within the CASP-3 gene which is why caspase-3 protein is not synthesized in
these cells.
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We then sought to elucidate a lysosomal-mediated pathway by which triptolide
induces apoptosis. This process is know to involve several lysosmal enzymes,
however acid phosphatase is known to exclusively be active within the acidic
conditions of the lysosomes. To test for lysosomal functionality we tested for the
activity of acid phosphatase and found that its activity was increased in 24 and 72 hour
treated cells relative to control cells. Also, using LysoTracker™ we localized
lysosomes within cells that were treated in the presence or absence of triptolide. Our
results were similar to the MitoTracker data in that there was an increase the
fluorescent intensity of the lysosomes in the experimental cells. Because of the role of
lysosomes in degrading cellular components and aiding in phagocytosis [29, 55],
establishing a link between triptolide and their activation will help to better explain
how apoptosis is achieved in these cells.
Lastly, we investigated the status of the chromatin in response to triptolide.
Through Western blot analysis we noticed that in triptolide treated cells, Bcl-2 was
down-regulated while p53 was up-regulated. This is in accordance with several other
studies [36, 52, 55] showing that the anti-apoptoitc proteins had decreased in
expression and pro-apoptotic ones increased when treated with anti-cancer agents.
PARP expression was also examined because of its roles in inducing apoptosis as well
as in repairing DNA damage. In the experimental cells, we noticed that PARP
expression was much higher than that of the control. And finally, to see if chromatin
condensation (one of the last stages of apoptosis) [56] was occurring, cells were stained
with Hoechst, and our experimental cells did show cells that had undergone chromatin
condensation. All of these studies collectively lead us to believe that triptolide39

associated apoptosis is mediated through multiple pathways including the increase of
p53, lysosomal-mediated apoptosis, and the mitochondrial role in the triggering of the
caspase cascade.
5. Conclusion

In summary, our results demonstrate mechanisms, besides the p53 pathway, by
which triptolide-treated breast cancer cells undergo apoptosis. Through the use of
homeopathic and natural treatments we may be able to find safer, non-invasive ways of
treating cancer. Future studies can investigate the effects of triptolide in vivo looking
at tumor volumes as well as protein expression from xenograft tumors in nude mice, as
well as through TUNEL analysis to determine if DNA fragmentation is occurring
suggesting that apoptosis is achieved in an animal model.
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